Hyperfractionated radiotherapy for Burkitt-type lymphoma. Radiobiological aspects.
Neoplasma
; 38(6): 609-15, 1991.
Article
em En
| MEDLINE
| ID: mdl-1766486
ABSTRACT
A case of Burkitt-type lymphoma treated by accelerated hyperfractionated irradiation combined with the COP chemotherapy is presented. The effectiveness of treatment was evaluated on the basis of the growth curve and the radiobiological aspects are discussed. During the treatment, the initial volume doubling time (Td) of 15 days was shortened to 4.5 days suggesting accelerated tumor growth. From dose response curve estimated for clinical data taken from literature, an effDo of 1.37 Gy was calculated. Surviving fraction after 58 Gy given in the twice-a-day regimen (b. i. d.) was 10(-19) suggesting local tumor control. However, only partial remission was observed. This nonradical effect may likely result in accelerated repopulation of surviving tumor clonogenic cells. This suggests that such a fast growing tumor as Burkitt-type lymphoma (Tpot = 1 day) should be irradiated using three instead two fractions per day combined with adjuvant or concomitant chemotherapy with a short intervals between cycles.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Maxilomandibulares
/
Linfoma de Burkitt
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Neoplasma
Ano de publicação:
1991
Tipo de documento:
Article
País de afiliação:
Polônia